These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 304488

  • 21. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC, Rodrigues D.
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [Abstract] [Full Text] [Related]

  • 22. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
    Igarashi T, Rodrigues D, Ting CC.
    J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
    [Abstract] [Full Text] [Related]

  • 23. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.
    Cheever MA, Greenberg PD, Fefer A.
    J Immunol; 1980 Aug; 125(2):711-4. PubMed ID: 6156213
    [Abstract] [Full Text] [Related]

  • 24. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ, Rosenstein M, Spiess PJ, Rosenberg SA.
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [Abstract] [Full Text] [Related]

  • 25. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
    Schultz KR, Klarnet JP, Gieni RS, HayGlass KT, Greenberg PD.
    Science; 1990 Aug 24; 249(4971):921-3. PubMed ID: 2118273
    [Abstract] [Full Text] [Related]

  • 26. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
    Greenberg PD, Kern DE, Cheever MA.
    J Exp Med; 1985 May 01; 161(5):1122-34. PubMed ID: 3921652
    [Abstract] [Full Text] [Related]

  • 27. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC, Law LW.
    J Immunol; 1977 Apr 01; 118(4):1259-64. PubMed ID: 191534
    [Abstract] [Full Text] [Related]

  • 28. Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors.
    Ting CC, Rodrigues D, Ting RC, Wivel N, Collins MJ.
    Int J Cancer; 1979 Nov 15; 24(5):644-55. PubMed ID: 160896
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages.
    Igarashi T, Teranishi T, Rodrigues D, Yamamura Y.
    Microbiol Immunol; 1980 Nov 15; 24(6):599-72. PubMed ID: 6968022
    [Abstract] [Full Text] [Related]

  • 34. Long term culture of tumour-specific cytotoxic T cells.
    Gillis S, Smith KA.
    Nature; 1977 Jul 14; 268(5616):154-6. PubMed ID: 145543
    [No Abstract] [Full Text] [Related]

  • 35. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb 14; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 36. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA, Peace DJ, Klarnet JP, Kern DE, Greenberg PD, Cheever MA.
    J Immunol; 1986 Dec 01; 137(11):3675-80. PubMed ID: 3491145
    [Abstract] [Full Text] [Related]

  • 37. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M, Kaplan AM.
    J Immunol; 1985 Aug 01; 135(2):1510-7. PubMed ID: 3159794
    [Abstract] [Full Text] [Related]

  • 38. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.
    Warnatz H, Scheiffarth F, Schmeissner R.
    Clin Exp Immunol; 1975 Aug 01; 21(2):250-8. PubMed ID: 1081024
    [Abstract] [Full Text] [Related]

  • 39. Preferential homing of passively transferred T cells into skin allografts of mice.
    Chang AE, Sugarbaker PH.
    Transplantation; 1979 Sep 01; 28(3):247-52. PubMed ID: 40333
    [Abstract] [Full Text] [Related]

  • 40. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
    Kitagawa M, Matsubara O, Kasuga T.
    Cancer Res; 1986 Jun 01; 46(6):3034-9. PubMed ID: 2870802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.